valsartan and Angioedema
valsartan has been researched along with Angioedema in 23 studies
Research
Studies (23)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bedhomme, S; Bouchant, S; Boussageon, R; Bœuf-Gibot, S; Charuel, E; Menini, T; Pereira, B; Piñol-Domenech, N; Vaillant-Roussel, H | 1 |
| Anand, IS; Boytsov, SA; Claggett, B; Cleland, J; Comin-Colet, J; Desai, AS; Düngen, HD; Ge, J; Goncalvesova, E; Gong, J; Jhund, PS; Katova, T; Kerr Saraiva, JF; Lam, CSP; Lefkowitz, MP; Lelonek, M; Maggioni, AP; Martinez, F; McMurray, JJV; Merkely, B; Packer, M; Pfeffer, MA; Pieske, B; Redfield, MM; Rizkala, AR; Rouleau, JL; Senni, M; Shah, SJ; Shi, VC; Solomon, SD; van Veldhuisen, DJ; Zannad, F; Zhou, J; Zile, MR | 1 |
| Dani, SS; Ganatra, S; Vaduganathan, M | 1 |
| Caldeira, D; Costa, J; David, C; Ferreira, JJ; Katerenchuk, V; Martins E Pereira, G; Pinto, FJ; S Duarte, G | 1 |
| Brar, S; D'Albo, N; Dani, SS; Dey, A; Ganatra, S; Kim, YS; Shah, S | 1 |
| Chrysant, SG | 1 |
| Barbera, V; Bellasi, A; Cozzolino, M; De Pascalis, A; Di Lullo, L; Floccari, F; Mudoni, A; Rivera, R; Ronco, C; Santoro, A; Verdesca, S | 1 |
| Kaplan, A; Modgill, V; Senni, M; Shi, V; Streefkerk, H; Zhou, W | 1 |
| Adie, S; Bitar, A; Dorsch, M; Hanigan, S; Koelling, T; Pogue, K | 1 |
| Baek, SH; Chiang, FT; Gotou, H; Inubushi-Molessa, A; Kario, K; Lefkowitz, M; Sun, N; Supasyndh, O; Zhang, J; Zhang, Y | 1 |
| Kamimura, R; Kawana, S; Nishisako, R; Urabe, T | 1 |
| Jacob, MS; Sabe, MA; Taylor, DO | 1 |
| Brown, NJ; Hubers, SA | 1 |
| Chapman, RH; Heidenreich, PA; Ollendorf, DA; Pearson, SD; Sandhu, AT | 1 |
| Brozena, S; Jessup, M; Owens, AT | 1 |
| Teerlink, JR; Tyler, JM | 1 |
| Cooley, C; Kalra, A; Palaniswamy, C; Zanotti-Cavazzoni, SL | 1 |
| Armstrong, SR; Budman, J; Cheruvu, M; Hegde, LG; Hegde, SS; Hill, CM; Klein, U; Lane, CE; Olsufka, R; Park, T; Renner, T; Sandvik, ER; Thibodeaux, H; Yu, C | 1 |
| Domínguez Ortega, FJ; Fuentes Gonzalo, MJ; Martínez Alonso, JC; Méndez Alcalde, J | 1 |
| Bork, K; Dewald, G | 1 |
| Arakawa, M; Murata, Y; Rikimaru, Y; Sasaki, Y | 1 |
| de la Serna Higuera, C | 1 |
| Vidt, DG | 1 |
Reviews
10 review(s) available for valsartan and Angioedema
| Article | Year |
|---|---|
Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta-analysis.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Drug Combinations; Heart Failure; Hospitalization; Humans; Hyperkalemia; Hypotension; Mortality; Renal Insufficiency; Risk Assessment; Stroke Volume; Valsartan | 2021 |
Angioedema with sacubitril/valsartan: Trial-level meta-analysis of over 14,000 patients and real-world evidence to date.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Stroke Volume; Tetrazoles; Valsartan | 2021 |
Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Drug Combinations; Humans; Hypotension; Randomized Controlled Trials as Topic; Risk; Tetrazoles; Valsartan | 2021 |
Five Years of Sacubitril/Valsartan-a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Hyperkalemia; Hypotension; Kidney Diseases; Pharmacovigilance; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2022 |
Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Clinical Trials as Topic; Cough; Cyclic GMP; Diuresis; Drug Combinations; Heart Failure; Heart Ventricles; Humans; Hypertension; Natriuretic Peptide, Brain; Neprilysin; Peptide Fragments; Renin-Angiotensin System; Stroke Volume; Tetrazoles; Valsartan; Vasodilation | 2017 |
[Neprilysin inhibition and chronic kidney disease].
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Disease Progression; Diuresis; Drug Combinations; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Models, Biological; Molecular Targeted Therapy; Natriuresis; Natriuretic Peptides; Neprilysin; Proteinuria; Renal Insufficiency, Chronic; Renin-Angiotensin System; Tetrazoles; Valsartan | 2017 |
Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Topics: Abnormalities, Drug-Induced; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Bradykinin; Contraindications; Drug Combinations; Drug Costs; Drug Synergism; Enalapril; Enzyme Inhibitors; Female; Follow-Up Studies; Heart Failure; Humans; Hyperkalemia; Hypertension; Kidney; Multicenter Studies as Topic; Natriuretic Peptides; Neprilysin; Pregnancy; Prodrugs; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Stroke Volume; Tetrazoles; Thiazepines; Valsartan | 2016 |
Neprilysin Inhibitors: Emerging Therapy for Heart Failure.
Topics: Alzheimer Disease; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Neprilysin; Patient Selection; Pyridines; Stroke Volume; Tetrazoles; Thiazepines; Valsartan | 2017 |
The safety of sacubitril-valsartan for the treatment of chronic heart failure.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Chronic Disease; Drug Combinations; Enalapril; Heart Failure; Humans; Risk Factors; Tetrazoles; Valsartan | 2017 |
Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review.
Topics: Aged, 80 and over; Angioedema; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hypertension; Tetrazoles; Time Factors; Valine; Valsartan | 2012 |
Trials
4 trial(s) available for valsartan and Angioedema
| Article | Year |
|---|---|
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Topics: Aged; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypotension; Male; Middle Aged; Neprilysin; Quality of Life; Sex Factors; Single-Blind Method; Stroke Volume; Tetrazoles; Valsartan | 2019 |
Angioedema in heart failure patients treated with sacubitril/valsartan (LCZ696) or enalapril in the PARADIGM-HF study.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Allergic Agents; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Enalapril; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Risk Assessment; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2018 |
Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Asian People; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Neprilysin; Republic of Korea; Taiwan; Tetrazoles; Thailand; Treatment Outcome; Valsartan | 2014 |
A new class of drugs for systolic heart failure: The PARADIGM-HF study.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiovascular Diseases; Cough; Double-Blind Method; Drug Combinations; Enalapril; Female; Heart Failure, Systolic; Hospitalization; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Neprilysin; Renal Insufficiency; Tetrazoles; Valsartan | 2015 |
Other Studies
9 other study(ies) available for valsartan and Angioedema
| Article | Year |
|---|---|
Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure.
Topics: Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cohort Studies; Drug Combinations; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Hyperkalemia; Hypotension; Male; Middle Aged; Retrospective Studies; Tetrazoles; Valsartan | 2019 |
[Case of drug-induced angioedema (DIAE) on induction of anesthesia with difficult ventilation due to oropharyngeal edema].
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Angioedema; Angiotensin Receptor Antagonists; Edema; Humans; Intubation, Intratracheal; Male; Pharyngeal Diseases; Prostatectomy; Prostatic Neoplasms; Severity of Illness Index; Tetrazoles; Valine; Valsartan | 2014 |
Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction.
Topics: Aminobutyrates; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cost-Benefit Analysis; Drug Combinations; Heart Failure; Hospitalization; Humans; Lisinopril; Markov Chains; Middle Aged; Quality-Adjusted Life Years; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan | 2016 |
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Topics: Angioedema; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Indans; Male; Neprilysin; Propionates; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Thiazepines; Valine; Valsartan | 2011 |
Angioedema due to valsartan.
Topics: Aged; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Tetrazoles; Valine; Valsartan | 2003 |
Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex.
Topics: Aged; Angioedema; Angiotensin Receptor Antagonists; Antihypertensive Agents; Female; Humans; Losartan; Sex Factors; Tetrazoles; Valine; Valsartan | 2004 |
Drug-induced isolated visceral angioneurotic edema.
Topics: Adult; Angioedema; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranoproliferative; Humans; Lisinopril; Renal Dialysis; Tetrazoles; Valine; Valsartan | 2005 |
[Angioedema and urticarial reaction induced by valsartan].
Topics: Angioedema; Anti-Allergic Agents; Antihypertensive Agents; Antipruritics; Drug Eruptions; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Loratadine; Middle Aged; Tetrazoles; Time Factors; Urticaria; Valine; Valsartan | 2000 |
Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Topics: Acrylates; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Black or African American; Clinical Trials as Topic; Cough; Female; Humans; Imidazoles; Irbesartan; Losartan; Male; Randomized Controlled Trials as Topic; Sex Factors; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2001 |